Merck & Co. Costs, Expenses and Other increased by 23.3% to $12.98B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.3%, from $11.45B to $12.98B. Over 4 years (FY 2021 to FY 2025), Costs, Expenses and Other shows an upward trend with a 6.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A decrease relative to revenue indicates improved overall cost management and higher pre-tax margins.
This aggregate metric represents the total sum of all operating and non-operating costs incurred by the company before a...
Company-specific aggregation; comparable to 'Total Operating Expenses' plus 'Other Expenses' at peer firms.
is_mrk_costs_expenses_and_other| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.69B | $7.89B | $8.63B | $11.04B | $10.11B | $11.38B | $10.32B | $10.84B | $20.37B | $10.34B | $16.68B | $10.11B | $10.11B | $12.57B | $11.45B | $9.63B | $10.81B | $10.53B | $12.98B |
| QoQ Change | — | -18.6% | +9.5% | +27.9% | -8.5% | +12.6% | -9.3% | +5.0% | +88.0% | -49.2% | +61.3% | -39.4% | +0.0% | +24.4% | -8.9% | -16.0% | +12.3% | -2.6% | +23.3% |
| YoY Change | — | — | — | — | +4.3% | +44.2% | +19.5% | -1.8% | +101.6% | -9.1% | +61.6% | -6.8% | -50.4% | +21.5% | -31.3% | -4.7% | +6.9% | -16.2% | +13.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.